|Remdesivir for the treatment of Covid-19|
JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ...
New England Journal of Medicine 383 (19), 1813-1826, 2020
|Air Surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus|
SWX Ong, YK Tan, PY Chia, TH Lee, OT Ng, MSY Wong
|Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore|
BE Young, SWX Ong, S Kalimuddin, JG Low, SY Tan, J Loh, OT Ng, ...
Jama 323 (15), 1488-1494, 2020
|Remdesivir for 5 or 10 days in patients with severe Covid-19|
JD Goldman, DCB Lye, DS Hui, KM Marks, R Bruno, R Montejano, ...
New England Journal of Medicine 383 (19), 1827-1837, 2020
|Baricitinib plus remdesivir for hospitalized adults with Covid-19|
AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ...
New England Journal of Medicine 384 (9), 795-807, 2021
|Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients|
PY Chia, KK Coleman, YK Tan, SWX Ong, M Gum, SK Lau, XF Lim, ...
Nature communications 11 (1), 1-7, 2020
|Connecting clusters of COVID-19: an epidemiological and serological investigation|
SEF Yong, DE Anderson, WE Wei, J Pang, WN Chia, CW Tan, YL Teoh, ...
The Lancet Infectious Diseases 20 (7), 809-815, 2020
|Epidemiological and clinical predictors of COVID-19|
Y Sun, V Koh, K Marimuthu, OT Ng, B Young, S Vasoo, M Chan, VJM Lee, ...
Clinical Infectious Diseases 71 (15), 786-792, 2020
|SARS-CoV-2 infection among travelers returning from Wuhan, China|
OT Ng, K Marimuthu, PY Chia, V Koh, CJ Chiew, L De Wang, BE Young, ...
New England Journal of Medicine 382 (15), 1476-1478, 2020
|The novel coronavirus (SARS-CoV-2) pandemic|
LY Hsu, PY Chia, JF Lim
Ann Acad Med Singap 49 (3), 105-7, 2020
|Effect of vancomycin or daptomycin with vs without an antistaphylococcal β-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a …|
SYC Tong, DC Lye, D Yahav, A Sud, JO Robinson, J Nelson, S Archuleta, ...
Jama 323 (6), 527-537, 2020
|SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study|
OT Ng, K Marimuthu, V Koh, J Pang, KZ Linn, J Sun, L De Wang, WN Chia, ...
The Lancet infectious diseases 21 (3), 333-343, 2021
|Viral dynamics and immune correlates of COVID-19 disease severity.|
BE Young, SWX Ong, LFP Ng, DE Anderson, WN Chia, PY Chia, LW Ang, ...
Clinical infectious diseases: an official publication of the Infectious …, 2020
|Absence of contamination of personal protective equipment (PPE) by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)|
SWX Ong, YK Tan, S Sutjipto, PY Chia, BE Young, M Gum, SK Lau, ...
Infection Control & Hospital Epidemiology 41 (5), 614-616, 2020
|Progress and challenges towards point-of-care diagnostic development for dengue|
J Pang, PY Chia, DC Lye, YS Leo
Journal of clinical microbiology 55 (12), 3339-3349, 2017
|Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study|
PY Chia, SWX Ong, CJ Chiew, LW Ang, JM Chavatte, TM Mak, L Cui, ...
|Clinical and Virological Features of SARS-CoV-2 Variants of Concern: A Retrospective Cohort Study Comparing B. 1.1. 7 (Alpha), B. 1.315 (Beta), and B. 1.617. 2 (Delta)|
SWX Ong, CJ Chiew, LW Ang, TM Mak, L Cui, MPHS Toh, YD Lim, ...
|Longitudinal study of cellular and systemic cytokine signatures to define the dynamics of a balanced immune environment during disease manifestation in Zika virus–infected patients|
FM Lum, DCB Lye, JJL Tan, B Lee, PY Chia, TK Chua, SN Amrun, ...
The Journal of infectious diseases 218 (5), 814-824, 2018
|A midpoint perspective on the COVID-19 pandemic|
LY Hsu, PY Chia, S Vasoo
Singapore medical journal 61 (7), 381, 2020
|Clinical features of patients with Zika and dengue virus co-infection in Singapore|
PY Chia, HS Yew, H Ho, A Chow, SP Sadarangani, M Chan, YW Kam, ...
Journal of Infection 74 (6), 611-615, 2017